After Deutsche Bank and BMO Capital gave Linde (NYSE: LIN) a Buy rating last month, the company received another Buy, this time from UBS. Analyst Andrew Stott maintained a Buy rating on Linde yesterday and set a price target of EUR335.00. The company’s shares closed last Monday at $288.91.
According to TipRanks.com, Stott is a 4-star analyst with an average return of 9.2% and a 60.2% success rate. Stott covers the Basic Materials sector, focusing on stocks such as Wacker Chemie AG, Clariant AG, and LANXESS.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Linde with a $365.91 average price target, a 30.3% upside from current levels. In a report issued on March 6, J.P. Morgan also maintained a Buy rating on the stock.
Based on Linde’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $8.3 billion and net profit of $1.03 billion. In comparison, last year the company earned revenue of $7.27 billion and had a net profit of $770 million.
Based on the recent corporate insider activity of 115 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of LIN in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Founded in 2017, UK-based Linde Plc is a leading global industrial gases and engineering company. The company serves a variety of end markets including chemicals & refining, food & beverage, electronics, healthcare, manufacturing and primary metals. Linde generates revenues through the following segments: Americas, EMEA (Europe, Middle East & Africa), APAC (Asia Pacific), Engineering and Others.
Read More on LIN: